MTOR and neoplasm: One potential explanation of these results demonstrating reduced survival when an mTOR inhibitor was added to the therapeutic regimen in GB could be protective effects of mTOR inhibition in the context of the tumor microenvironment that we have previously shown in cell culture models [38].